From all of us at NORD, we'd like to say a huge thank you to our advocates who took the time over the past few months to #SaveOrphanDrugs. It was your passion that helped to keep the Orphan Drug Tax Credit (ODTC) from being repealed. Although the ODTC was cut down to nearly 25%, we have to remember that the House wanted to repeal the credit entirely. Learn more about this from NORD's Director of Federal Policy, Paul Melmeyer, in the video below and be sure to visit rareaction.org to become a member of the #RareAction Network in order to remain involved in #raredisease advocacy as we head into 2018.
